- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
黄芪和葶苈子加减治疗CHF的疗效及心脏彩超参数变化研究
葛乐品林梅瑟姜祖超陈鹏鹏曹隆檬李焱
[关键词]?黄芪和葶苈子;慢性心力衰竭;临床疗效;心脏彩超
[中图分类号]?R541.6??????[文献标识码]?A??????[DOI]?10.3969/j.issn.1673-9701.2024.12.016
Study?on?the?effect?of?addition?or?subtraction?of?Astragalus?membranaceus?and?Draba?nemorosa?on?CHF?and?changes?of?cardiac?color?ultrasound?parameters
GE?Lepin,?LIN?Meise,?JIANG?Zuchao,?CHEN?Pengpeng,?CAO?Longmeng,?LI?Yan
Department?of?Cardiovascular?Diseases,?Wenzhou?Hospital?of?Traditional?Chinese?Medicine,?Wenzhou?325000,?Zhejiang,?China
[Abstract]?Objective?To?analyze?the?efficacy?of?Astragalus?membranaceus?and?Draba?nemorosa?in?the?treatment?of?chronic?heart?failure?(CHF),?the?change?of?cardiac?color?ultrasound?parameters?and?its?predictive?value?for?adverse?end?events.?Methods?A?total?of?92?patients?with?Qi-deficiency?and?blood-stasis?combined?with?Shuiyin?CHF?treated?in?Wenzhou?Hospital?of?Traditional?Chinese?Medicine?from?September?2019?to?September?2021?were?randomly?selected?and?divided?into?two?groups?by?random?number?table?method,?with?46?cases?in?each?group.?Patients?in?control?group?were?received?conventional?Western?medicine?treatment,?and?patients?in?observation?group?were?received?the?addition?and?subtraction?treatment?of?Yiqi?Huoxue?Lishui?prescription?based?on?Astragalus?membranaceus?and?Draba?nemorosa.?The?clinical?efficacy,?TCM?syndrome?score,?heart?color?ultrasound?parameters?and?the?incidence?of?adverse?endpoint?events?within?6?months?were?compared?between?the?two?groups.?Cardiac?color?doppler?ultrasound?parameters?were?compared?between?the?occurrence?group?and?the?non-occurrence?group,?and?receiver?operating?characteristic?curve?was?drawn?to?analyze?the?predictive?value?of?cardiac?color?Doppler?ultrasound?parameters?for?adverse?end?events.?Results?The?total?clinical?effective?rate?of?the?observation?group?(95.65%)?was?higher?than?that?of?the?control?group?(71.74%)?(P0.05).?After?treatment,?palpitation,?weakness,?shortness?of?breath,?lethargy?and?lip?purple?score?in?observation?grou
文档评论(0)